On the cutting edge

Our innovative researchers make groundbreaking advances in the fight against cancer that help save lives around the world.

Research Programs
a woman wearing a mask uses a syringe in a research lab

Research

National Cancer Institute Designated Cancer Center logo

Today's research leads to tomorrow's cures.

MUSC Hollings Cancer Center is committed to translational science that accelerates lifesaving discoveries getting from the lab to the bedside to benefit our patients, both at Hollings and beyond. Hollings is home to more than 150 scientists conducting research and collaborating on better ways to prevent, detect, diagnose, and treat this complex disease. As one of 73 National Cancer Institute-designated cancer centers, Hollings continues to attract top cancer researchers from leading institutions across the country who conduct research in the community, laboratory, and clinic. The center has an annual research funding portfolio of over $50 million and offers more than 200 clinical trials.


“ This is lifesaving research we're doing to discover and invent new treatments, to test them, and to make sure the outcomes of our patients are improved by putting these new treatments in place. ”

Dr. Raymond DuBois, director of MUSC Hollings Cancer Center

Dr. Raymond DuBois wearing a white physician's coat

Clinical Trial Development

Are you a researcher or doctor with an idea for a clinical trial? The Hollings Advisory for Rapid Translation (HART) provides expertise and mentorship to help you develop your trial.

Learn about HART

Latest Research News

two cancer researchers pose in the garden

HPV Cancers

Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

Abirami Sivapiragasam consults with nurse in hallway

TNBC and Heart Disease

A clinical trial at Hollings is looking for answers to a problem that Dr. Avi Siva saw was affecting her triple negative breast cancer patients.

group photo of students and faculty members at Hollings Cancer Center

Cancer Researchers of Tomorrow

A new microcredential from Hollings Cancer Center highlights the work of future cancer researchers, who are learning both science and compassion.

Hollings Cancer Center (HCC) researcher Besim Ogretmen, Ph.D. is program coleader of Hollings Cancer Center's Developmental Cancer Therapeutics Research Program, and professor of Biochemistry and Molecular Biology at MUSC Hollings Cancer Center at the Medical University of South Carolina.

Mitochondrial Targeting

MUSC Hollings Cancer Center researchers are working on a new drug that destroys cancer cells' energy factories.

a man and woman pose in front of a wall bookshelf

Quit Vaping Help

New trial to test whether quit-smoking medication works to help people to quit vaping.

A cancer researcher watches as a student works in her lab

NCI Fellowship

MUSC student Thomas Blouin will use an NCI fellowship to study how a chemical that doesn't seem to change DNA still causes cancer.

HPV public health researcher Kalyani "Kelly" Sonawane

HPV-Cancer Connection

Many people remain unaware that HPV can cause six types of cancer – and that can affect whether people choose to vaccinate.

HPV cancers public health researcher Dr. Trisha Amboree poses at Hollings Cancer Center

Cervical Cancer Screening

Counties with historically lower rates of screening for cervical cancer have higher rates of late-stage diagnosis and death.

image of natural language processing researcher Jihad Obeid

Using AI to Improve Care

Details in medical record notes are often critical to proper care. AI can help highlight those notes as patients move among doctors in different specialties.

More Research News

Education & Training

group photo of 2019 SC CHEC student fellows

Hollings is committed to developing the researchers who will go on to make cancer research breakthroughs in the years ahead. Starting with high school students, Hollings offers education, training, mentoring, and career development opportunities across all levels.

Learn about our programs

Funding Opportunities

researcher works with equipment in the lab

Hollings offers intramural support opportunities for students, postdoctoral trainees, and faculty conducting cancer-related research and clinical services.

Learn about funding

Hollings Membership

Hollings seeks MUSC faculty who have an interest in cancer research and provides opportunities for interactions and collaboration among investigators with common interests. Members are given priority access to Hollings-supported shared resources and are eligible to apply for pilot project funding.

Become a member